Philip Morris International (PMI) has announced the release of a new tobacco-free pod product designed to be used with their IQOS heating device. The company claims that this device can heat small tobacco pouches, similar to cigarettes, without burning them, resulting in potentially reduced health risks compared to smoking. PMI has developed a range of pods called LEVIA, which they claim do not contain tobacco but instead are infused with a substance called "non-tobacco matrix" that contains nicotine. The flavors available include tobacco, blueberry mint, and mint.
In his investor day report, Jacek Olczak, CEO of PMI International, stated that this product not only offers consumers an alternative to tobacco that they may not wish to use, but also potentially benefits from low-tax policies. Olczak further mentioned that LEVIA may not be subject to flavor regulations in certain jurisdictions and may not fit into existing fiscal categories. He added that PMI is currently in discussions with regulators in target markets regarding how they will address this issue.
The company advocates that, compared to traditional cigarettes, the industry refers to its product as a "reduced-risk" alternative, which can decrease the risk of exposure to harmful chemicals compared to smoking. Therefore, it should enjoy reduced taxation. The U.S. Food and Drug Administration (FDA) has authorized PMI to market IQOS. However, the World Health Organization (WHO) states that there is currently no evidence to suggest that heated tobacco poses lower health risks compared to other tobacco products.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
